Labcorp (LH) EVP Anita Graham reports RSU vesting and tax share withholding

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Anita Z. Graham, EVP and CHRO, reported multiple equity transactions involving company stock and restricted stock units (RSUs). On February 6 and 7, 2026, RSUs converted into common stock (coded "M"), reflecting scheduled vesting from prior grants.

To cover tax withholding obligations, a portion of the newly delivered shares was withheld and disposed of (coded "F") at prices of $277.20 and $274.01 per share, rather than sold in an open-market trade. Each RSU represents the right to receive one share of common stock, and the filing notes grants vesting in three equal annual installments beginning on February 6, 2025 and February 7, 2024.

Following these transactions, Graham directly holds 1,213 shares of Labcorp common stock, as well as outstanding RSU balances as reflected in the derivative securities table.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GRAHAM ANITA Z

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CHRO

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M		327	A	(1)	1,077	D
Common Stock	02/06/2026		F(2)		119	D	$277.2	958	D
Common Stock	02/07/2026		M		367	A	(1)	1,325	D
Common Stock	02/09/2026		F(2)		112	D	$274.01	1,213	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/06/2026		M			327	(3)	(3)	Common Stock	327	$0	1,764(4)	D
Restricted Stock Unit	(1)	02/07/2026		M			367	(5)	(5)	Common Stock	367	$0	1,397(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

5. The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Anita Z. Graham	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Labcorp (LH) report for EVP Anita Z. Graham?

Labcorp reported that EVP and CHRO Anita Z. Graham had restricted stock units convert into common shares, with some shares withheld to satisfy tax obligations. These equity events are part of her existing compensation arrangements, not new open-market purchases or discretionary stock sales.

How many Labcorp (LH) shares does Anita Z. Graham hold after these Form 4 transactions?

After the reported transactions, Anita Z. Graham directly holds 1,213 shares of Labcorp common stock. The filing also shows outstanding restricted stock unit balances, which represent additional rights to receive shares in the future, separate from her currently owned common stock position.

What do the "M" and "F" transaction codes mean in the Labcorp (LH) Form 4?

In this Form 4, code "M" indicates the conversion of restricted stock units into common shares. Code "F" reflects shares withheld to cover tax withholding obligations. These codes show equity award vesting and related tax-share withholding, rather than ordinary market trading activity by the executive.

How do Labcorp (LH) restricted stock units work in Anita Z. Graham’s compensation?

Each restricted stock unit represents the contingent right to receive one share of Labcorp common stock. The filing notes grants that vest in three equal annual installments starting February 6, 2025 and February 7, 2024, aligning share delivery with multi-year service and performance periods.

Were the Labcorp (LH) insider transactions open-market sales by Anita Z. Graham?

The Form 4 shows stock withholding transactions, coded "F", used to satisfy tax withholding obligations when restricted stock units vested. This indicates shares were withheld for taxes rather than sold through discretionary open-market sales initiated by Anita Z. Graham on an exchange.

What RSU vesting schedules are disclosed for Labcorp (LH) executive Anita Z. Graham?

The filing states that one RSU grant vests in three equal annual installments beginning February 6, 2025, while another vests in three equal annual installments beginning February 7, 2024 and is now fully vested. These schedules govern when units convert into Labcorp common shares.